A Phase 1b Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults

Trial Profile

A Phase 1b Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Dec 2016

At a glance

  • Drugs MEDI 7510 (Primary)
  • Indications Respiratory syncytial virus infections
  • Focus Adverse reactions
  • Sponsors MedImmune
  • Most Recent Events

    • 17 May 2016 Status changed from active, no longer recruiting to completed.
    • 10 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
    • 15 Jan 2015 Planned number of patients changed from 240 to 264, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top